Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend

NEW YORK--(BUSINESS WIRE)-- The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent fourth-quarter 2011 dividend on the company’s common stock, payable December 6, 2011, to shareholders of record at the close of business on November 11, 2011.

The fourth-quarter 2011 cash dividend will be the 292nd consecutive quarterly dividend paid by Pfizer.



CONTACT:

Pfizer Inc.

Joan Campion (media)
212-733-2798
Suzanne Harnett (investors)
212-733-8009

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

Biogen will develop a gene therapy with the goal of preserving and possibly restoring vision in patients with PRPF31-mutated retinitis pigmentosa.

A month after moving its COVID-19 antibody cocktail into human trials, Regeneron is testing the drug's ability to ward off COVID-19 infection.

Short reports are nothing new, but the aggressive “I’m coming after you” PR from Applied Therapeutics certainly is.